George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.95
Bid: 34.85
Ask: 35.00
Change: 0.05 (0.14%)
Spread: 0.15 (0.43%)
Open: 35.75
High: 35.75
Low: 34.45
Prev. Close: 34.90
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

24 May 2018 16:05

RNS Number : 2438P
Alliance Pharma PLC
24 May 2018
 

TR-1: Standard form for notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Alliance Pharma plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

GVQ Investment Management Limited

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)

Name

Chase Nominees Ltd & Nortrust Nominees Ltd

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

23/05/18

6. Date on which issuer notified (DD/MM/YYYY):

24/05/18

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

4.98%

4.98%

475,410,395

Position of previous notification (if

applicable)

5.05%

5.05%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0031030819

23,691,460

4.98%

SUBTOTAL 8. A

23,691,460

4.98%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

settlement

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information

 

Place of completion

London, SW1A 1NX

Date of completion

24/05/18

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEASSLAEAPEFF
Date   Source Headline
17th Jun 20155:30 pmRNSDirector Shareholding
1st Jun 20153:30 pmRNSExercise of Share Options
27th May 20152:00 pmRNSShare Options
27th May 20157:00 amRNSAGM Statement
20th Apr 20157:00 amRNSHardman & Co issues research report
15th Apr 20157:00 amRNSExercise of Share Options
10th Apr 20157:00 amRNSAnnual Report and AGM Notice
25th Mar 20157:00 amRNSPreliminary Results
3rd Mar 20159:30 amRNSExercise of Share Options
17th Feb 20157:00 amRNSDirectorate Change
16th Feb 20157:00 amRNSNotification of Preliminary Results
2nd Feb 201512:15 pmRNSAcquisition of MacuVision
26th Jan 20157:00 amRNSAppointment of Non-Executive Director
19th Jan 20157:00 amRNSPre-Close Trading Update
18th Dec 20143:27 pmRNSDirectorate Change
10th Sep 20147:00 amRNSAlliance Pharma PLC Interim Results
5th Aug 20147:00 amRNSNotification of Interim Results
9th Jul 20147:00 amRNSPre-Close Trading Update
19th Jun 20145:35 pmRNSExercise of Share Options
21st May 20147:00 amRNSAGM Statement
11th Apr 20142:30 pmRNSShare Options
11th Apr 20147:00 amRNSMajor Interest in Shares
10th Apr 20142:57 pmRNSExercise of Share Options
10th Apr 20147:00 amRNSAnnual Report and Notice of AGM
7th Apr 20142:45 pmRNSTR-1: Notification of Major Interest in Shares
1st Apr 20147:00 amRNSAppointment of Non-Executive Director
26th Mar 20147:00 amRNSPreliminary Results
4th Feb 20147:00 amRNSNotification of Preliminary Results
23rd Jan 20149:30 amRNSTR-1: Notification of Major Interest in Shares
20th Jan 20147:00 amRNSDirector Shareholding
14th Jan 20147:00 amRNSAcquisition in Germany
14th Jan 20147:00 amRNSPre-Close Trading Update
30th Dec 20132:00 pmRNSDirectorate Change
19th Dec 20132:45 pmRNSCULS Conversion and Additional Listing
18th Dec 20137:00 amRNSAcquisition of Lypsyl
9th Dec 20137:00 amRNSMajor Interest in Shares
2nd Dec 20136:00 pmRNSCULS Conversion and Additional Listing
11th Nov 20134:20 pmRNSCULS Conversion and Additional Listing
7th Nov 20131:46 pmRNSCompulsory Conversion of CULS
28th Oct 20133:01 pmRNSCULS Conversion and Additional Listing
25th Oct 20138:00 amRNSMajor Interest in Shares
24th Oct 20135:55 pmRNSShare Options
22nd Oct 20139:30 amRNSCULS Conversion and Additional Listing
11th Oct 20137:00 amRNS£55 Million Bank Facilities
16th Sep 20132:01 pmRNSCULS Conversion and Additional Listing
11th Sep 20137:00 amRNSInterim Results
10th Sep 20135:51 pmRNSCULS Conversion and Additional Listing
27th Aug 20133:03 pmRNSCULS Conversion and Additional Listing
1st Aug 20137:00 amRNSNotification of Half Year Results
11th Jul 20137:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.